Emerging Therapies for COVID-19: The Value of Information From More Clinical Trials

OBJECTIVES: The COVID-19 pandemic necessitates time-sensitive policy and implementation decisions regarding new therapies in the face of uncertainty. This study aimed to quantify consequences of approving therapies or pursuing further research: immediate approval, use only in research, approval with...

Descripción completa

Detalles Bibliográficos
Autores principales: Dijk, Stijntje W., Krijkamp, Eline M., Kunst, Natalia, Gross, Cary P., Wong, John B., Hunink, M.G. Myriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc. 2022
Materias:
Themed Section: COVID-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045876/
https://www.ncbi.nlm.nih.gov/pubmed/35490085
http://dx.doi.org/10.1016/j.jval.2022.03.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045876/
https://www.ncbi.nlm.nih.gov/pubmed/35490085
http://dx.doi.org/10.1016/j.jval.2022.03.016

Ejemplares similares